Heparin Versus Bivalirudin Monotherapy in the Setting of Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction.

about

Heparin Versus Bivalirudin Monotherapy in the Setting of Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction.

Item

http://www.wikidata.org/entity/Q38383037

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Heparin Versus Bivalirudin Mon ...... evation Myocardial Infarction.

@en

type

Item

label

Heparin Versus Bivalirudin Mon ...... evation Myocardial Infarction.

@en

prefLabel

Heparin Versus Bivalirudin Mon ...... evation Myocardial Infarction.

@en

P1476

Heparin Versus Bivalirudin Mon ...... evation Myocardial Infarction.

@en

P2093

Janna C Beavers

http://www.w3.org/2001/XMLSchema#string

Kathleen D Faulkenberg

http://www.w3.org/2001/XMLSchema#string

Shannon W Finks

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Bivalirudin for patients with acute coronary syndromes

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

Bivalirudin during primary PCI in acute myocardial infarction

Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMA

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial.

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction.

P304

141-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028015618206

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26681442

http://www.w3.org/2001/XMLSchema#string